$7.52 Billion is the total value of Matrix Capital Management Company, LP's 29 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NFLX | NETFLIX INC | $1,000,060,000 | +9.9% | 2,000,000 | 0.0% | 13.29% | -6.3% | |
CRM | SALESFORCE COM INC | $659,039,000 | +34.2% | 2,622,309 | 0.0% | 8.76% | +14.4% | |
TDG | TRANSDIGM GROUP INC | $520,209,000 | +7.5% | 1,094,900 | 0.0% | 6.91% | -8.4% | |
CRWD | CROWDSTRIKE HLDGS INCcl a | $411,960,000 | +36.9% | 3,000,000 | 0.0% | 5.48% | +16.7% | |
ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $311,014,000 | -20.3% | 38,974,185 | 0.0% | 4.13% | -32.0% | |
DOCU | DOCUSIGN INC | $289,534,000 | +25.0% | 1,345,166 | 0.0% | 3.85% | +6.6% | |
WDAY | WORKDAY INCcl a | $227,187,000 | +14.8% | 1,056,043 | 0.0% | 3.02% | -2.1% | |
ALTR | ALTAIR ENGR INC | $173,660,000 | +5.6% | 4,136,725 | 0.0% | 2.31% | -9.9% | |
AMZN | AMAZON COM INC | $162,160,000 | +14.1% | 51,500 | 0.0% | 2.16% | -2.7% | |
ZNTL | ZENTALIS PHARMACEUTICALS INC | $124,933,000 | -31.9% | 3,821,739 | 0.0% | 1.66% | -42.0% | |
LVGO | LIVONGO HEALTH INC | $107,550,000 | +86.3% | 767,943 | 0.0% | 1.43% | +58.8% | |
GWRE | GUIDEWIRE SOFTWARE INC | $41,708,000 | -5.9% | 400,000 | 0.0% | 0.55% | -19.8% | |
RNA | AVIDITY BIOSCIENCES INC | $33,780,000 | -0.4% | 1,200,000 | 0.0% | 0.45% | -15.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TRANSDIGM GROUP INC | 42 | Q3 2023 | 13.3% |
WORKDAY INC | 42 | Q3 2023 | 19.7% |
NETFLIX INC | 37 | Q2 2022 | 26.1% |
NEW RELIC INC | 29 | Q1 2022 | 7.8% |
DAVITA INC | 26 | Q3 2019 | 6.1% |
ADAPTIMMUNE THERAPEUTICS PLC | 26 | Q3 2023 | 6.8% |
SALESFORCE INC | 23 | Q3 2022 | 18.4% |
CONSTELLATION BRANDS INC | 23 | Q2 2019 | 5.7% |
AMAZON COM INC | 21 | Q3 2023 | 11.2% |
TABLEAU SOFTWARE INC | 20 | Q2 2019 | 15.2% |
View Matrix Capital Management Company, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | July 10, 2023 | 233,845,110 | 17.3% |
Zentalis Pharmaceuticals, Inc. | June 20, 2023 | 13,959,973 | 19.8% |
ForgeRock, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
NEW RELIC, INC.Sold out | February 13, 2023 | 0 | 0.0% |
Perimeter Solutions, SA | February 13, 2023 | 8,587,500 | 5.4% |
Aura Biosciences, Inc. | December 07, 2022 | 5,362,870 | 14.5% |
Adaptive Biotechnologies Corp | February 14, 2022 | 11,572,590 | 8.2% |
BigCommerce Holdings, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
CarGurus, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
Trillium Therapeutics Inc.Sold out | February 14, 2020 | 0 | 0.0% |
View Matrix Capital Management Company, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
13F-HR | 2023-11-14 |
4 | 2023-11-09 |
SC 13D/A | 2023-11-09 |
13F-HR | 2023-08-14 |
SC 13G/A | 2023-07-10 |
4 | 2023-06-20 |
SC 13D/A | 2023-06-20 |
13F-HR | 2023-05-15 |
View Matrix Capital Management Company, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.